Cargando…
Ornithine transcarbamylase downregulation is associated with poor prognosis in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-associated mortalities worldwide. The role of ornithine transcarbamylase (OTC) in HCC remains unclear. In the present study, the expression of OTC in HCC was analyzed based on datasets from the Gene Expression Omnibus database of...
Autores principales: | He, Lin, Cai, Xuefei, Cheng, Shengtao, Zhou, Hongzhong, Zhang, Zhenzhen, Ren, Jihua, Ren, Fang, Yang, Qiuxia, Tao, Nana, Chen, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507468/ https://www.ncbi.nlm.nih.gov/pubmed/31186714 http://dx.doi.org/10.3892/ol.2019.10174 |
Ejemplares similares
-
Hepatocellular Adenoma in a Patient with Ornithine Transcarbamylase Deficiency
por: Cheng, Lin, et al.
Publicado: (2019) -
Antepartum Ornithine Transcarbamylase Deficiency
por: Nakajima, Hitoshi, et al.
Publicado: (2014) -
Gene Mutation Analysis and Prenatal Diagnosis of the Ornithine Transcarbamylase (OTC) Gene in Two Families with Ornithine Transcarbamylase Deficiency
por: Li, Sitao, et al.
Publicado: (2018) -
Three-Country Snapshot of Ornithine Transcarbamylase Deficiency
por: Seker Yilmaz, Berna, et al.
Publicado: (2022) -
Ornithine Transcarbamylase – From Structure to Metabolism: An Update
por: Couchet, Morgane, et al.
Publicado: (2021)